These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29360267)

  • 1. MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation.
    Li Y; Li L; Chen M; Yu X; Gu Z; Qiu H; Qin G; Long Q; Fu X; Liu T; Li W; Huang W; Shi D; Kang T; Luo M; Wu X; Deng W
    Mol Oncol; 2018 Mar; 12(3):391-405. PubMed ID: 29360267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.
    Li L; Jiang P; Hu W; Zou F; Li M; Rao T; Ruan Y; Yu W; Ning J; Cheng F
    J Transl Med; 2024 Mar; 22(1):295. PubMed ID: 38515112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive expression of basic transcription factor 3 predicts poor survival of colorectal cancer patients: possible mechanisms involved.
    Liu Q; Wu J; Lu T; Fang Z; Huang Z; Lu S; Dai C; Li M
    Cell Death Dis; 2019 Jul; 10(7):509. PubMed ID: 31263147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma Susceptibility.
    de Semir D; Bezrookove V; Nosrati M; Dar AA; Miller JR; Leong SP; Kim KB; Liao W; Soroceanu L; McAllister S; Debs RJ; Schadendorf D; Leachman SA; Cleaver JE; Kashani-Sabet M
    Cancer Res; 2021 Jun; 81(11):2956-2969. PubMed ID: 33766890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma.
    Liu Z; Wang S; Yu K; Chen K; Zhao L; Zhang J; Dai K; Zhao P
    J Transl Med; 2023 Nov; 21(1):863. PubMed ID: 38017538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine residues 639 and 673 of mouse Ncoa3 are ubiquitination sites for the regulation of its stability.
    Mou C; Zhang Y; Zhang W; Ding Y; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2014 Dec; 46(12):1066-71. PubMed ID: 25348736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic feature of mitotic arrest deficient 2-like protein 2 (MAD2L2) and structural basis for its interaction with chromosome alignment-maintaining phosphoprotein (CAMP).
    Hara K; Taharazako S; Ikeda M; Fujita H; Mikami Y; Kikuchi S; Hishiki A; Yokoyama H; Ishikawa Y; Kanno SI; Tanaka K; Hashimoto H
    J Biol Chem; 2017 Oct; 292(43):17658-17667. PubMed ID: 28887307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy.
    Shen T; Cai LD; Liu YH; Li S; Gan WJ; Li XM; Wang JR; Guo PD; Zhou Q; Lu XX; Sun LN; Li JM
    J Hematol Oncol; 2018 Jul; 11(1):95. PubMed ID: 30016968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAD2L2, a key regulator in ovarian cancer and promoting tumor progression.
    Xu K; Zheng X; Shi H; Ou J; Ding H
    Sci Rep; 2024 Jan; 14(1):130. PubMed ID: 38167649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.
    Ao X; Nie P; Wu B; Xu W; Zhang T; Wang S; Chang H; Zou Z
    Cell Death Dis; 2016 Nov; 7(11):e2463. PubMed ID: 27831559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequestration of CDH1 by MAD2L2 prevents premature APC/C activation prior to anaphase onset.
    Listovsky T; Sale JE
    J Cell Biol; 2013 Oct; 203(1):87-100. PubMed ID: 24100295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
    Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
    Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sevoflurane suppresses colorectal cancer malignancy by modulating β-catenin ubiquitination degradation via circSKA3.
    Song W; Miao L; Zhang K; Liu Y; Lin J; Li J; Huang Z; Cao D; Zhang Y; Hu C
    Cell Signal; 2024 Feb; 114():110987. PubMed ID: 38029946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator.
    Zheng X; Jia Y; Qiu L; Zeng X; Xu L; Wei M; Huang C; Liu C; Chen L; Han J
    J Biol Chem; 2020 Feb; 295(6):1474-1488. PubMed ID: 31914406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
    Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplifications of NCOA3 gene in colorectal cancers in a Chinese population.
    Li Z; Fang ZY; Ding Y; Yao WT; Yang Y; Zhu ZQ; Wang W; Zhang QX
    World J Gastroenterol; 2012 Feb; 18(8):855-60. PubMed ID: 22371647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells.
    Zhai P; Zhang H; Li Q; Hu Z; Zhang H; Yang M; Xing C; Guo Y
    Clin Exp Metastasis; 2024 Oct; 41(5):747-764. PubMed ID: 38796806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive feedback of SuFu negating protein 1 on Hedgehog signaling promotes colorectal tumor growth.
    Yan Z; Cheng M; Hu G; Wang Y; Zeng S; Huang A; Xu L; Liu Y; Shi C; Deng L; Lu Q; Rao H; Lu H; Chen YG; Luo S
    Cell Death Dis; 2021 Feb; 12(2):199. PubMed ID: 33608498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis.
    Fang Y; Shen ZY; Zhan YZ; Feng XC; Chen KL; Li YS; Deng HJ; Pan SM; Wu DH; Ding Y
    Nat Commun; 2019 Sep; 10(1):3981. PubMed ID: 31484922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.